Lateral Flow Immunoassays for Ebola Virus Disease Detection in Liberia

Journal of Infectious Diseases

Volumn 214, Issue , 2016, Pages S222-S228

  Phan, Jill C ^a   Pettitt, James ^b   George, Josiah S ^d   Fakoli, Lawrence S ^d   Taweh, Fahn M ^d   Bateman, Stacey L ^c   Bennett, Richard S ^b   Norris, Sarah L ^c   Spinnler, David A ^a   Pimentel, Guillermo ^a   Sahr, Phillip K ^d   Bolay, Fatorma K ^d   Schoepp, Randal J ^c  

^a Laboratory of Genomics   (China)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^d Liberian Institute for Biomedical Research   (United States)

Author keywords

Antibodies; Diagnostics; Ebola; Ebola virus disease; EBOV; EVD; Immunoassay; Lateral flow; LFI; Liberia; West Africa

Indexed keywords

VIRUS GLYCOPROTEIN; VIRUS NUCLEOPROTEIN; GLYCOPROTEIN; NUCLEOPROTEIN;

ANTIGEN DETECTION; ARTICLE; BENCHMARKING; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EBOLA HEMORRHAGIC FEVER; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LATERAL FLOW IMMUNOASSAY; LIBERIA; MAJOR CLINICAL STUDY; MOUTH EXAMINATION; NONHUMAN; POINT OF CARE TESTING; POST MORTEM ORAL SWAB; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; REAL TIME POLYMERASE CHAIN REACTION; RED BLOOD CELL SEPARATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; COMPARATIVE STUDY; EBOLAVIRUS; EPIDEMIC; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; ISOLATION AND PURIFICATION; POINT OF CARE SYSTEM; PROCEDURES; PUBLIC HEALTH; VIROLOGY;

DISEASE OUTBREAKS; EBOLAVIRUS; GLYCOPROTEINS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOASSAY; LIBERIA; NUCLEOPROTEINS; POINT-OF-CARE SYSTEMS; PUBLIC HEALTH; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84990937780     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw251     Document Type: Article

References (16)

1. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371:1418-25.
2. World Health Organization. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/. Accessed 8 August 2014.
3. US Food and Drug Administration. Authorization of emergency use of an in vitro diagnostic device for detection of Ebola Zaire virus; availability. https://www.federalregister.gov/articles/2014/09/17/2014-22086/authorization-of-emergencyuse-of-an-in-vitro-diagnostic-device-for-detection-of-ebola-zaire-virus. Accessed 17 September 2014.
4. World Health Organization. Selection and use of Ebola in vitro diagnostic (IVD) assays, emergency guidance. http://apps.who.int/iris/bitstream/10665/175554/1/WHO-EVD-HIS-EMP-15.2-eng.pdf?ua=1&ua=1. Accessed June 2015.
5. Posthuma-Trumpie GA, Korf J, van Amerongen A. Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey. Anal Bioanal Chem 2009; 393:569-82.
6. Trombley AR, Wachter L, Garrison J, et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg 2010; 82:954-60.
7. Lado M,Walker NF, Baker P, et al. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis 2015; 15:1024-33.
8. Zachariah R, Harries AD. The WHO clinical case definition for suspected cases of Ebola virus disease arriving at Ebola holding units: reason to worry? Lancet Infect Dis 2015; 15:989-90.
9. Shears P, O'Dempsey TJ. Ebola virus disease in Africa: epidemiology and nosocomial transmission. J Hosp Infect 2015; 90:1-9.
10. Richards P, Amara J, Ferme MC, et al. Social pathways for Ebola virus disease in rural Sierra Leone, and some implications for containment. PLoS Negl Trop Dis 2015; 9:e0003567.
11. Formenty P, Leroy EM, Epelboin A, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006; 42:1521-6.
12. Grolla A, Jones SM, Fernando L, et al. The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis 2011; 5:e1183.
13. Walker NF, Brown CS, Youkee D, et al. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Euro Surveill 2015; 20:1-6.
14. Broadhurst MJ, Kelly JD, Miller A, et al. ReEBOVAntigen Rapid Test kit for pointof-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet 2015; 386:867-74.
15. Rougeron V, Feldmann H, Grard G, Becker S, Leroy EM. Ebola and Marburg haemorrhagic fever. J Clin Virol 2015; 64:111-9.
16. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-41.